1.

Record Nr.

UNINA9910349556803321

Titolo

Intrahepatic Cholangiocarcinoma : Diagnosis and Management / / edited by Timothy M. Pawlik, Jordan M. Cloyd, Mary Dillhoff

Pubbl/distr/stampa

Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019

ISBN

3-030-22258-6

Edizione

[1st ed. 2019.]

Descrizione fisica

1 online resource (221 pages)

Disciplina

616.99436

Soggetti

Surgery

Surgical oncology

General Surgery

Surgical Oncology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di contenuto

Epidemiology and Risk Factors -- Clinical Presentation and Diagnosis -- Staging and Prognosis -- Imaging -- Surgical Treatment -- Management of the Nodal Basin -- Pathologic Assessment -- Systemic Therapy -- Percutaneous Ablation -- Transarterial Therapies -- Radiotherapy -- Molecular Pathogenesis: From Inflammation And Cholestasis To A Microenvironment-Driven Tumor -- Clinical Trials and Novel/Emerging Treatment.

Sommario/riassunto

This book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC). It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care. The book was organized and written to aid the clinician’s understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients. Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included.



An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options. Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.